172 related articles for article (PubMed ID: 8042263)
1. Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis.
Höbarth K; Hofbauer J; Szabo N
Urology; 1994 Jul; 44(1):20-4; discussion 24-5. PubMed ID: 8042263
[TBL] [Abstract][Full Text] [Related]
2. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
[TBL] [Abstract][Full Text] [Related]
3. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
4. Value of routine citrate analysis and calcium/citrate ratio in calcium urolithiasis.
Höbarth K; Hofbauer J
Eur Urol; 1991; 19(2):165-8. PubMed ID: 2022221
[TBL] [Abstract][Full Text] [Related]
5. Is hypocitraturia associated with phosphaturia--a potential cause of calcium urolithiasis in first-time stone formers.
Khand FD; Ansari AF; Khand TU; Memon JM
J Pak Med Assoc; 1994 Aug; 44(8):179-81. PubMed ID: 7996662
[TBL] [Abstract][Full Text] [Related]
6. On the relation between citrate and calcium in normal and stone-former subjects.
Conte A; Roca P; Gianotti M; Grases F
Int Urol Nephrol; 1990; 22(1):7-12. PubMed ID: 2380005
[TBL] [Abstract][Full Text] [Related]
7. Screening for biochemical abnormalities in urolithiasis patients.
Orakzai N; Hanbury DC; Farrington K
J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
[TBL] [Abstract][Full Text] [Related]
8. Calcium-to-Citrate Ratio Distinguishes Solitary and Recurrent Urinary Stone Forming Children.
DeFoor W; Jackson E; Schulte M; Alam Z; Asplin J
J Urol; 2017 Aug; 198(2):416-421. PubMed ID: 28365270
[TBL] [Abstract][Full Text] [Related]
9. Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis.
Hosking DH; Wilson JW; Liedtke RR; Smith LH; Wilson DM
J Lab Clin Med; 1985 Dec; 106(6):682-9. PubMed ID: 4067380
[TBL] [Abstract][Full Text] [Related]
10. Metabolic evaluation in stone patients in relation to extracorporeal shock wave lithotripsy treatment.
Lycklama à Nijeholt GA; Tan HK; Papapoulos SE
J Urol; 1991 Dec; 146(6):1478-81. PubMed ID: 1942322
[TBL] [Abstract][Full Text] [Related]
11. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
Berg C; Larsson L; Tiselius HG
J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
[TBL] [Abstract][Full Text] [Related]
12. Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans.
Song S; Thomas IC; Ganesan C; Sohlberg EM; Chertow GM; Liao JC; Conti S; Elliott CS; Pao AC; Leppert JT
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1773-1780. PubMed ID: 31712387
[TBL] [Abstract][Full Text] [Related]
13. Stone formation and urine composition in calcium stone formers without medical treatment.
Bek-Jensen H; Tiselius HG
Eur Urol; 1989; 16(2):144-50. PubMed ID: 2714332
[TBL] [Abstract][Full Text] [Related]
14. The most important metabolic risk factors in recurrent urinary stone formers.
Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
[TBL] [Abstract][Full Text] [Related]
15. Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.
Nikkilä MT
Urol Int; 1989; 44(3):157-9. PubMed ID: 2749930
[TBL] [Abstract][Full Text] [Related]
16. Promoters and inhibitors of calcium urolithiasis in children.
Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
[TBL] [Abstract][Full Text] [Related]
17. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
Doizi S; Poindexter JR; Pearle MS; Blanco F; Moe OW; Sakhaee K; Maalouf NM
J Urol; 2018 Dec; 200(6):1278-1284. PubMed ID: 30036516
[TBL] [Abstract][Full Text] [Related]
18. Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males.
Cupisti A; Morelli E; Lupetti S; Meola M; Barsotti G
Nephron; 1992; 61(1):73-6. PubMed ID: 1528345
[TBL] [Abstract][Full Text] [Related]
19. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
20. Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers.
Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Moeding A; Stessman M; Anderson JK; Monga M
J Endourol; 2011 Mar; 25(3):535-40. PubMed ID: 21361824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
